Strata Critical Medical (SRTA) Change in Receivables (2021 - 2026)

Strata Critical Medical has disclosed Change in Receivables across 6 years of filings, most recently posting -$149000.0 for Q1 2026.

• In Q1 2026, Change in Receivables fell 128.65% year-over-year to -$149000.0; the TTM figure through Mar 2026 stood at $11.4 million (up 1141.7% YoY), while the FY2025 annual figure was $12.0 million, up 1105.81% from the prior year.
• Change in Receivables eased to -$149000.0 in Q1 2026, from $3.5 million in the prior quarter.
• Over the last five years, Change in Receivables for SRTA reached as high as $6.3 million in Q2 2025 and fell as low as -$3.4 million in Q3 2024.
• The 5-year median for Change in Receivables is $1.8 million (2025), against an average of $1.8 million.
• Annual changes were most pronounced in 2023 — Change in Receivables surged 1101.08% — and 2024, when it tumbled 1990.4%.
• A 5-year view of Change in Receivables shows it stood at $4.1 million in 2022, then slumped by 103.03% to -$125000.0 in 2023, then plunged by 1990.4% to -$2.6 million in 2024, then soared by 233.3% to $3.5 million in 2025, then slumped by 104.28% to -$149000.0 in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$149000.0, $3.5 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.